Tissue engineering devices for the repair and regeneration of tissue

• US 20060153815A1
• Filed: 12/15/2005
• Published: 07/13/2006
• Est. Priority Date: 12/21/2004
• Status: Abandoned Application

• Current Assignee: Ethicon Incorporated (Johnson & Johnson)
• Original Assignee: Ethicon Incorporated (Johnson & Johnson)
• Inventors: Gosiewska, Anna, Colter, David C., Seyda, Agnieszka, Dhanaraj, Sridevi, Geesin, Jeffrey C., Scopelianos, Angelo, Buensuceso, Charito S.
• Application Number:
  US11/304,091
• Publication Number:
  US 20060153815A1
• Time in Patent Office: Days
• US Class Current: 424/93.700
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/38 containing added animal cells organs or tissue containing native cells A61L27/36
• CPC Class Codes: C12N 2533/40 Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
• CPC Class Codes: C12N 5/0068 General culture methods using substrates for specific animal cell type C12N5/06

Abstract

Tissue engineering devices for use in the repair or regeneration of tissue made of support scaffolds and cell sheets.

Claims

1. A tissue engineering device for use in the repair or regeneration of tissue comprised of a support scaffold layer and a cell sheet layer.

2. The tissue engineering device of claim 1 wherein said cell sheet layer is comprised of cells selected from the group consisting of chondrocytes, osteoblasts, fibroblasts, angioblasts, myoblasts, epithelial cells, urothelial cells, smooth muscle cells, keratinocytes, beta cells, endothelial cells, fibrocytes, vascular endothelial cells, hepatocytes, small intestine epithelial cells, epidermal keratinocytes, bone marrow mesenchymal cells, cardiomyocytes, intervertebral disc cells, oral mucosal epithelia, gastrointestinal mucosal epithelia, urinary tract epithelia, skeletal joint synovium, periosteum, perichondrium, skeletal muscle cells, smooth muscle cells, cardiac muscle cells, pericardium, dura, meninges, keratinocyte precursor cells, pericytes, glial cells, neural cells, amniotic membrane, placental membrane, serosal cells, undifferentiated stem cells, undifferentiated progenitor cells, pre-differentiated stem cells, pre-differentiated progenitor cells, neural stem cells, neural progenitor cells, neuronal cells, dendritic cells, and genetically engineered cells.

3. The tissue engineering device of claim 1 wherein said cell sheet layer is comprised of stem cells.

4. The tissue engineering device of claim 3 wherein said stem cells are selected from the group consisting of hematopoietic, mesenchymal, postpartum, pancreatic, hepatic, retinal epithelial, olfactory bulb, endothelial, muscle, adipose-derived, ileac crest, bone marrow, periodontal ligament, oval and dermal cells and organ specific stem and progenitor cells.

5. The tissue engineering device of claim 1 wherein said cell sheet layer further comprises extracellular matrix protein.

6. The tissue engineering device of claim 5 wherein said extracellular matrix protein is selected from the group consisting of collagens, laminins, fibronectin, vitronectin, tenascin, integrins, hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparan sulfate, heparin, keratan sulfate, chitosan, cellulose, oxidized regenerated cellulose, elastin and fibrin.

7. The tissue engineering device of claim 1 wherein said cell sheet layer further comprises growth factor.

8. The tissue engineering device of claim 7 wherein said growth factor is selected from the group consisting of vascular endothelial cell growth factor, platelet derived growth factor, epidermal growth factor, fibroblast growth factor, hepatocyte growth factor, insulin-like growth factor, brain derived neurotrophic factor, growth differentiation factor-5, EPO, and transforming growth factor.

9. The tissue engineering device of claim 1 wherein said cell sheet layer further comprises a reinforcing member.

10. The tissue engineering device of claim 9 wherein said reinforcing member is selected from the group consisting of weave, knit, braid, film, perforated film, mesh, and non-woven.

11. The tissue engineering device of claim 9 wherein said reinforcing member is a non-woven mesh comprised of poly(glycolic acid)/poly(lactic acid) copolymer fibers.

12. The tissue engineering device of claim 1 wherein said support scaffold layer comprises a biodegradable homopolymer, copolymer or polymer blend comprised of monomers selected from the group consisting of lactide, glycolide, epsilon-caprolactone, 1,4-dioxan-2-one, 1,3-dioxan-2-one, and alkyl derivatives of trimethylene carbonate.

13. The tissue engineering device of claim 1 wherein said support scaffold layer comprises a polymer selected from the group consisting of fibrin-based material, collagen-based material, hyaluronic acid-based material, glycoprotein-based material, cellulose-based material, and silk.

14. The tissue engineering device of claim 1 wherein said support scaffold layer is selected from the group consisting of weaves, knits, braids, non-wovens, warped knits, meshes, porous foams, semiporous foams, and perforated sheets.

15. The tissue engineering device of claim 1 wherein said support scaffold layer is a porous foams comprised of poly(epsilon-caprolactone)/poly(glycolic acid) copolymer.

16. The tissue engineering device of claim 1 wherein said support scaffold layer is a non-woven mesh comprised of polyglycolic acid.

17. The tissue engineering device of claim 16 wherein said support scaffold layer is coated with 50/50 mol percent poly(lactic acid-co-glycolic acid).